CDK4 anticorps (AA 272-303)
Aperçu rapide pour CDK4 anticorps (AA 272-303) (ABIN3030610)
Antigène
Voir toutes CDK4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 272-303
-
Purification
- Antigen affinity purified
-
Immunogène
- A portion of amino acids 272-303 from the rat protein was used as the immunogen for this Cdk4 antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Titration of the Cdk4 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. IHC (Paraffin): 1:25,Immunofluorescence: 1:25
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the Cdk4 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- CDK4 (Cyclin-Dependent Kinase 4 (CDK4))
-
Autre désignation
- Cdk4
-
Sujet
- Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex (By similarity).
-
UniProt
- P35426
-
Pathways
- Cycle Cellulaire, Mitotic G1-G1/S Phases, Regulation of Cell Size
Antigène
-